Vakzine Projekt Management GmbH   Report issue

For profit Phase 3
Founded: Hannover Germany (2002)

Organization Overview

First Clinical Trial
2008
NCT00749034
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Vakzine Projekt Management GmbH

Active Ingredients

Drugs in Phase 3 Trials (1)

bacille calmette-guerin (7 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 3)

Infections (Phase 3)

Latent Tuberculosis (Phase 3)

Mycobacterium Infections (Phase 3)

Respiratory Tract Infections (Phase 3)

Tuberculosis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 7
  • # of Trial APIs: 1